Brief: Evolent Health Q2 Revenue USD 647.145 Million Vs. IBES Estimate USD 636.4 Million
08/08/2024 21:10
Aug 08 (Reuters) - Evolent Health Q2 net income USD -6.383 million vs. IBES estimate USD 30.5 million. * Q2 adjusted EBITDA margin 8% * Q2 adjusted EBITDA USD 51.95 million vs. IBES estimate USD 54 million * outlook FY adjusted EBITDA USD 230-245 million * outlook Q3 adjusted EBITDA USD 60-68 million
Recent news on Evolent Health
See all newsEvolent Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Evolent Health Q2 revenue beats expectations
Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview
Evolent Health Q1 revenue misses estimates as margin narrows